Florida Cancer Specialists | Strategic Alliance Partners

May 24, 2022

Medical oncologist Michael Diaz, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC, is the recipient of the Florida Society of Clinical Oncology Dorothy Green Phillips Legacy Award 2022.

May 24, 2022

Martin F. Dietrich, MD, PhD, highlights recent updates in mantle cell lymphoma treatment, explains how new developments have raised sequencing questions, and projects where future research efforts will focus.

May 10, 2022

The American Cancer Society reported earlier this year that the risk of dying from cancer in the United States has decreased by 32% over the past 28 years, which translates to almost 3.5 million fewer cancer deaths.

April 25, 2022

Two medical oncologists from Florida Cancer Specialists & Research Institute participated in the Florida Society of Clinical Oncology Fellow & Resident Educational Training Program. The program featured respected keynote speakers to share helpful information for transitioning into the oncology workforce.

April 12, 2022

Martin Dietrich, MD, PhD, discusses optimizing treatment options for patients with mantle cell lymphoma.

April 04, 2022

Florida Cancer Specialists & Research Institute launched a new website to host a variety of top articles ranging from recent oncology and hematology studies to new therapies, even topics on value-based care.

April 01, 2022

Martin Dietrich, MD, PhD, discusses the current treatment landscape of mantle cell lymphoma.

March 31, 2022

Margarett Ellison, MD, gynecologic oncologist with Gynecologic Oncology of Tallahassee, A Division of Florida Cancer Specialists & Research Institute, has been designated as a National GYN Oncology Observation Site for Intuitive Surgical.

March 28, 2022

Florida Cancer Specialists and Research Institute welcomed Ken Sturtz, MBA, MHA to its executive leadership team as Chief Information Officer.

March 10, 2022

Joshua Eaves joined the Florida Cancer Specialists & Research Institute senior management team as senior vice president, corporate development.

February 22, 2022

Skill, passion and teamwork. Essential elements for patient centered partnerships.

February 15, 2022

The survival rate for Americans diagnosed with several of the most common cancers has increased dramatically in the past nearly three decades, thanks in large part to scientific discoveries and treatment advances.

January 20, 2022

Florida Cancer Specialists Nurse Receives Inaugural MBC Heroes™ Award from CURE Media Group.

January 19, 2022

Cesar Augusto Perez, MD, discusses the potential utility of KIN-2787 in BRAF-mutated solid tumors.

November 29, 2021

Florida Cancer Specialists & Research Institute held a ribbon-cutting ceremony to mark the opening of its new state-of-the-art cancer center in Manatee County.

November 18, 2021

Tampa General Hospital, the Florida Cancer Specialists & Research Institute, Proton Therapy Partners, and Florida Urology Partners announced a new collaborative partnership with plans to build a proton therapy center in Tampa Bay.

November 16, 2021

Florida Cancer Specialists & Research Institute opened its new state-of-the-art Trinity Cancer Center, providing the most advanced and personalized treatments and services for patients with all forms of cancers and blood disorders.

November 12, 2021

Florida Cancer Specialists & Research Institute, in collaboration with AdventHealth Heart of Florida and Central Florida Cancer Institute, has received a three-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons.

October 26, 2021

Florida Cancer Specialists & Research Institute has opened its new state-of-the-art North Port Cancer Center, providing the most advanced and personalized treatments and services for patients with all forms of cancers and blood disorders.

October 22, 2021

Three medical oncologists at Florida Cancer Specialists & Research Institute are co-authors on a new integrated safety analysis of umbralisib, used to treat lymphoid malignancies.